Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1987;9:444-450

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Svetkey, L. P.
Right arrow Articles by Klotman, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Svetkey, L. P.
Right arrow Articles by Klotman, P. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*POTASSIUM CHLORIDE

Hypertension, Vol 9, 444-450, Copyright © 1987 by American Heart Association


ARTICLES

Double-blind, placebo-controlled trial of potassium chloride in the treatment of mild hypertension

LP Svetkey, WE Yarger, JR Feussner, E DeLong and PE Klotman

Epidemiological and experimental data suggest blood pressure-lowering effects of dietary potassium. A randomized, double-blind clinical trial was used to assess blood pressure response to orally administered potassium, 120 mEq/day, and to placebo in 101 adults with mild hypertension. Blood pressure was measured with a random-zero sphygmomanometer every 2 weeks of this 8-week trial. Systolic blood pressure in the potassium-treated group decreased by 6.4 +/- 13.7 (SD) mm Hg (p less than or equal to 0.025) compared with 0.11 +/- 13.0 mm Hg in the placebo-treated group (p = 0.96). Diastolic blood pressure in the potassium-treated group decreased by 4.1 +/- 8.3 mm Hg (p less than or equal to 0.05) compared with a 1.6 +/- 6.5 mm Hg decrease in placebo- treated subjects (p = 0.09). Baseline blood pressure of potassium- treated subjects was unexpectedly higher than that of controls. After correcting for baseline variation, blood pressure still decreased 3.4/1.8 mm Hg more in potassium recipients than in placebo recipients (p = 0.14 and 0.24, respectively). Blood pressure decreased by 19/13 mm Hg in five blacks taking potassium versus a 1/0 mm Hg increase in seven blacks taking placebo. Compliance with the potassium regimen was 91.5% by pill count; only one subject discontinued treatment because of side effects. In conclusion, 120 mEq/day of microencapsulated potassium chloride was well tolerated in adults with mild hypertension. An antihypertensive effect of potassium cannot be ruled out despite the fact that there was no statistically significant difference between potassium-treated and placebo-treated subjects after adjustment for differences in baseline blood pressure.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
HypertensionHome page
D. K. Wilson, D. A. Sica, and S. B. Miller
Effects of Potassium on Blood Pressure in Salt-Sensitive and Salt-Resistant Black Adolescents
Hypertension, August 1, 1999; 34(2): 181 - 186.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. Jin, L. Chao, and J. Chao
Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2 receptor in SHR
Am J Physiol Renal Physiol, March 1, 1999; 276(3): F476 - F484.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
L. P. Svetkey, D. Simons-Morton, W. M. Vollmer, L. J. Appel, P. R. Conlin, D. H. Ryan, J. Ard, B. M. Kennedy, and for the DASH Research Group
Effects of Dietary Patterns on Blood Pressure: Subgroup Analysis of the Dietary Approaches to Stop Hypertension (DASH) Randomized Clinical Trial
Arch Intern Med, February 8, 1999; 159(3): 285 - 293.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. M. Sacks, W. C. Willett, A. Smith, L. E. Brown, B. Rosner, and T. J. Moore
Effect on Blood Pressure of Potassium, Calcium, and Magnesium in Women With Low Habitual Intake
Hypertension, January 1, 1998; 31(1): 131 - 138.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. K. Whelton, J. He, J. A. Cutler, F. L. Brancati, L. J. Appel, D. Follmann, and M. J. Klag
Effects of Oral Potassium on Blood Pressure: Meta-analysis of Randomized Controlled Clinical Trials
JAMA, May 28, 1997; 277(20): 1624 - 1632.
[Abstract] [PDF]


Home page
HypertensionHome page
K. Sudhir, A. Forman, S.-L. Yi, J. Sorof, O. Schmidlin, A. Sebastian, and R. C. Morris Jr
Reduced Dietary Potassium Reversibly Enhances Vasopressor Response to Stress in African Americans
Hypertension, May 1, 1997; 29(5): 1083 - 1090.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
F. L. Brancati, L. J. Appel, A. J. Seidler, and P. K. Whelton
Effect of Potassium Supplementation on Blood Pressure in African Americans on a Low-Potassium Diet: A Randomized, Double-blind, Placebo-Controlled Trial
Arch Intern Med, January 8, 1996; 156(1): 61 - 67.
[Abstract] [PDF]


Home page
Arch Fam MedHome page
C. K. Lardinois
Nutritional Factors and Hypertension
Arch Fam Med, August 1, 1995; 4(8): 707 - 713.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
National High Blood Pressure Education Program Working Group Report on Primary Prevention of Hypertension
Arch Intern Med, January 25, 1993; 153(2): 186 - 208.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
A. Siani, P. Strazzullo, A. Giacco, D. Pacioni, E. Celentano, and M. Mancini
Increasing the Dietary Potassium Intake Reduces the Need for Antihypertensive Medication
Ann Intern Med, November 15, 1991; 115(10): 753 - 759.
[Abstract] [PDF]